The Food and Drug Administration will convene a meeting of external digital health advisors on Nov. 6, according to an email reviewed by STAT. The gathering comes as the agency wrestles with myriad issues related to regulating artificial intelligence and other technologies in health care.

The email, addressed to members of and consultants to the FDA’s Digital Health Advisory Committee, said the virtual-only meeting would be announced publicly no later than Sept. 10. No topic was given, but the email said an agenda and discussion questions were forthcoming.

Another source involved with the committee told STAT they had not been notified of the meeting. The FDA did not immediately respond to a request for comment.

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page